Literature DB >> 3541495

Muscarinic receptor density in the rat urinary bladder after denervation, hypertrophy and urinary diversion.

L Nilvebrant, J Ekström, L Malmberg.   

Abstract

Parasympathetic denervation of the urinary bladder results in supersensitivity to muscarinic agonists and in bladder hypertrophy. In the present study, the effects of denervation on the muscarinic receptors in the rat bladder were investigated, using a receptor binding technique with (-)3H-QNB as radioligand. The density of muscarinic receptors was increased in denervated, hypertrophied bladders but it was decreased, below that in control bladders, when the development of hypertrophy was prevented by urinary diversion. A decreased receptor density was also found in innervated bladders after urinary diversion, whereas the receptor density was unaffected by hypertrophy alone. Competition experiments with methacholine revealed no changes in the agonist binding properties of the receptors. When the present data are combined with those in previous functional studies, it seems unlikely that the muscarinic receptors in the bladder are involved in the development of supersensitivity. It is suggested that the density of muscarinic receptors in the bladder may be related to the bladder function.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3541495     DOI: 10.1111/j.1600-0773.1986.tb00174.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  5 in total

Review 1.  Muscarinic receptors: what we know.

Authors:  Harriette M Scarpero; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2003-12       Impact factor: 3.092

2.  M2 receptors in genito-urinary smooth muscle pathology.

Authors:  A Braverman; J Legos; W Young; G Luthin; M Ruggieri
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

3.  M2 muscarinic receptor contributes to contraction of the denervated rat urinary bladder.

Authors:  A S Braverman; G R Luthin; M R Ruggieri
Journal:  Am J Physiol       Date:  1998-11

4.  Cardiovascular safety and overall tolerability of solifenacin in routine clinical use: a 12-week, open-label, post-marketing surveillance study.

Authors:  Martin C Michel; Ulrich Wetterauer; Monika Vogel; Jean J M C H de la Rosette
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

5.  Hypertrophy changes the muscarinic receptor subtype mediating bladder contraction from M3 toward M2.

Authors:  Alan S Braverman; Michael R Ruggieri
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-05-22       Impact factor: 3.619

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.